HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for COVID-19

German Nutraceuticals Market Growth Slows In 2022 But Vitamin C Remains Popular

The growth of sales of nutraceuticals through German pharmacy is slowing post-pandemic, according to IQVIA data. However, there were still double-digit gains for vitamin C and multivitamin products.

Germany Wellness

Over The Counter 20 March 2023: The Shape Of The Global OTC Market To Come, With IQVIA Consumer Health's Amit Shukla

In this episode, HBW Insight catches up with IQVIA Consumer Health’s vice president of global consulting services, Amit Shukla, to find out how the global consumer healthcare market is performing as it comes out of the pandemic. It’s good news, Shukla reveals, based on the firm’s latest intelligence. The market grew double digits in 2022 and is predicted to expand by 5-6% per year in the future - even faster if some of the innovative switches currently in the pipeline succeed. Shukla points to artificial intelligence, sustainability and popular wellness ingredients as trends to watch that will drive future market growth.

Health International

US Still Rinsing Out OTC Sanitizer Warnings

Of GMP warnings for OTC hand sanitizers, 114 have been submitted by FDA since pandemic began, with first sent in late April 2020, and another 12 for false COVID-19 claims, with first sent on 1 April. One GMP warning for hand sanitizer product is listed in both 2018 and 2019.

Coronavirus COVID-19 FDA

Resilience, ‘Lessons Learned’ Must Be COVID Legacy In Germany

COVID-19 threat is abating and control measures easing, but government commitments made at height of pandemic to forearm against future health care emergencies should not be abandoned, says German Advisory Council on Health and Care and the IVD industry.

Consumer Coronavirus COVID-19

For Reauthoring Preparedness Law, Congress Needs Advice On Next Public Health Emergency

House Energy and Commerce members seek input as appropriate mix of incentives for next-generation, public-private ventures remains elusive.

Consumer Coronavirus COVID-19

Health Care Professionals Settle With FTC Over COVID-19 Claims For Direct Seller’s Supplements

Three distributors made claims doTerra's essential oils and supplements could treat or prevent COVID-19 in early 2022webinars. They also underscored medical expertise in recommending products.

Coronavirus COVID-19 Ad Complaints

Over The Counter 6 March 2023: A Guide To Post-Pandemic Consumer Healthcare Marketing, With Kaizo’s Kerry Lennox

In this episode, HBW Insight speaks to UK PR firm Kaizo’s associate director Kerry Lennox about consumer healthcare marketing in the post-pandemic context. With consumers bombarded by healthcare messaging and increasingly anxious about their health and wellness, Lennox explains how OTC firms can play a key role in supporting responsible self-care. As trust shifts away from governments and scientific experts towards front-line healthcare professionals like pharmacists, OTC brands are becoming more important to consumers, helping them “tune back in” to science-based health and wellness while supporting this crucial part of the healthcare ecosystem.

United Kingdom Health

EUA For First At-Home Kit Differentiating COVID-19 From Flu Could Be Difference In Firm’s Survival

Sales authorized for first test providing at-home results including differentiating flu from COVID. Lucira gets EUA for its COVID-19 & Flu Test two days after filing for Chapter 11 bankruptcy protection, indicating it would seek buyer.

Coronavirus COVID-19 FDA
See All